Ficus hispida fruit compounded tea tablets capable of reducing blood glucose and preparation method for ficus hispida fruit compounded tea tablet

Abstract

The invention belongs to the technical field of healthcare food, and particularly relates to ficus hispida fruit compounded tea tablets capable of reducing the blood glucose and a preparation method for the ficus hispida fruit compounded tea tablets. The ficus hispida fruit compounded tea tablets are prepared from the following raw materials in parts by weight: 20 to 30 parts of green tea, 6 to 10 parts of an aquilaria sinensis fresh leaf, 3 to 9 parts of a ficus hispida fruit, 2 to 6 parts of immature psidium guajava, 0.4 to 1.2 parts of raw dark green tea, 2 to 4 parts of cordyceps militaris, 0.4 to 0.8 part of artificially cultured dendrobium officinale green shoot, 0.4 to 0.6 part of edible grade eurotium cristatum liquid, 0.2 to 0.4 part of saccharomyces cerevisiae liquid and 0.002 to 0.008 part of Pullulan. Processes comprise fixation, extraction, fermentation, mixing, pressing, drying under the reduced pressure, and packaging. The ficus hispida fruit compounded tea tablets have the characteristics of quick-acting reduction of the blood glucose, treatment of the diabetes mellitus, good flavor taste, convenience in taking and the like.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a tea tablet for lowering blood sugar compounded with banyan fruit and a preparation method thereof. Background technique [0002] According to the monitoring results of the Guangdong Provincial Center for Disease Control and Prevention in 2013, the prevalence of adult diabetes in Guangdong Province was 13%, higher than the national rate of 11.6%. The research team led by the former chairman of the Endocrinology Society of the Chinese Medical Association, Professor Ning Guang of the School of Medicine of Shanghai Jiao Tong University, and Zhao Wenhua of the Chinese Center for Disease Control and Prevention found that half of Chinese adults are diabetic reserves, and the nightmare of the "sick man of East Asia" seems to be coming again. This data highlights the seriousness and urgency of the diabetes prevention and control situation. For this reason, the inventor has...

AI Technical Summary

Problems solved by technology

For this reason, the inventor has completed an invention of "a health tea for preventing and treating diabetes (patent number: ZL201310233340.4), which consists of dried guava slices, ginseng flower buds, dried leaves of miracle fruit, peeled ganoderma lucidum, golden Huafuzhuan black tea is used as raw material, which is made through pulverization, steam sterilization, mixed fermentation, drying, and packaging. However, through further research and practice, it is found that it still has the following defects: ①The yield of ginseng flower buds is extremely low, and the cost of raw materials is high. Not suitable for large-scale production; ②The bitter substances of Ganoderma lucidum are ganoderma esters, which belong to triterpenoids. At present, there are 106 kinds of triterpenoids known, which are one of the main functional components of Ganoderma lucidum. The more bitter the taste, the more effective Strong, removes most of the bitter substances, which is not conducive to the full play of the efficacy of Ganoderma lucidum, and also wastes resources; ③The dried leaves of the miracle fruit have not been approved by the Ministry of Health to be used in medicine, and have not been approved to be used as new resource food raw materials, thus making the product The safety and applicability have not been fully recognized, which is not conducive to rapid promotion and application; ④The amount of Saccharomyces coronoidis contained in Fuzhuan dark tea is insufficient, and the activity is not strong, so that the fermentation takes a long time and the fermentation effect is not enough Sufficient; ⑤ need to use the finished Fuzhuan dark tea as the main raw material for reprocessing, which greatly increases the cost; ⑥ hypoglycemic effect is still weak, can only be used for general prevention and health care drinking, for patients with obvious hyperglycemia, the hypoglycemic effect not strong enough